Adding vitamin B3 to water may prevent glaucoma

In a study on mice, scientists from The Jackson Laboratory in Bar Harbor, Maine, found it helped to keep their eyes healthier for longer - reducing their risk of developing the condition.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Conclusions: A phenotype corresponding to combined monosomy 6p25 and trisomy 18p11 presented as childhood glaucoma associated with non-acquired (congenital) ocular anomalies consist of aniridia and Peters anomaly and other systemic malformations. To the best of our knowledge, this is the first report which demonstrated the breakpoint sequence of an unbalanced translocation in a Japanese infant with childhood glaucoma. PMID: 32223580 [PubMed - as supplied by publisher]
Source: Ophthalmic Genetics - Category: Opthalmology Tags: Ophthalmic Genet Source Type: research
CONCLUSION: Treatment of glaucoma with prostaglandins and beta blockers has a significant importance in HTG. However, beta blockers have a higher protective effect on the visual field. This is not true in NTG, where we demonstrated this effect only following the administration of beta blockers. PMID: 32225997 [PubMed - as supplied by publisher]
Source: Biomedical Papers of the Medical Faculty of the Univ Palacky Olomouc Czech Repub - Category: Biomedical Science Tags: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Source Type: research
Conclusions: LSCD associated with glaucoma surgery has clinical features distinct from LSCD resulting from other etiologies. Further study is required to delineate the full impact of glaucoma surgery on limbal stem cell function and survival.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
Conclusions: Our 5-year clinical results of nDSAEK and DSAEK did not show significant differences at almost all points.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
In conclusion, the different severities of glaucoma do not alter the incidence of subsequent dementia.
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
Publication date: Available online 30 March 2020Source: Microvascular ResearchAuthor(s): Aizhu Tao, Yuanbo Liang, Juanjuan Chen, Haishuang Hu, Qiangjie Huang, Jingwei Zheng, Cong Ye, Fan Lu
Source: Microvascular Research - Category: Biochemistry Source Type: research
Journal of Ocular Pharmacology and Therapeutics, Ahead of Print.
Source: Journal of Ocular Pharmacology and Therapeutics - Category: Opthalmology Authors: Source Type: research
AbstractPurpose of ReviewTo review the current understanding of the pathophysiology and management of aqueous misdirection syndrome.Recent FindingsAqueous misdirection syndrome represents a spectrum of disorders that converge on a common pathway of increasing posterior segment pressure and secondary angle closure glaucoma. Although the etiology of aqueous misdirection remains unclear and is likely multifactorial, recent data supports choroidal expansion as an inciting event in the pathogenesis of the syndrome. As such, the term aqueous misdirection may be a misnomer. Some would argue that the use of terminology such as acu...
Source: Current Ophthalmology Reports - Category: Opthalmology Source Type: research
Second Sight Medical Products is the latest medtech company to face tough losses as a result of the financial impact of the novel coronavirus (SARS-CoV-2). The Sylmar, CA-based company is laying off 84 of its 108 employees and said it intends to wind-down operations. The firm develops implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals. FDA greenlit the Argus II retinal prosthesis system in 2013. Plans now call for the Second Sight to retain an adviser experienced in winding down operations to guide the board on the next steps. Any wind down activity, if impl...
Source: MDDI - Category: Medical Devices Authors: Tags: Implants Business Source Type: news
Conditions:   Glaucoma;   Diabetic Retinopathy;   Refractive Errors;   Cataract;   Behavior, Health Interventions:   Other: No Financial Incentive;   Behavioral: Financial Incentive Sponsors:   University of Alabama at Birmingham;   Centers for Disease Control and Prevention Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Eyes | Glaucoma | Health | Laboratory Medicine | Study | Vitamin B3 | Vitamins